| 04 December 2017

ProRetina Germany Announce the Potsdam Meeting - April 13 & 14, 2018

PRO RETINA Germany invites you to the 13th International Research Colloquium on Retinal Degeneration to be held in beautiful Potsdam, Templiner See, from April 13 to 14, 2018.

From Franz Badura - President - PRO RETINA Germany 

Over two days, we will address recent advances in the field of retinal diseases. Specifically, we will focus on retinal pigment epithelium and the potential of this highly functionalized monolayer as a target for treatment in retinal degenerations, including age-related macular degeneration (AMD). We will also discuss current activities in gene therapy approaches for selected monogenic retinal dystrophies and will look at the present state of knowledge in disease causes and treatment designs for both early and late stage AMD. These topics will be presented by national and international experts in the field and will provide a basis for vivid scientific exchanges.

The meeting will start with a keynote lecture presented by Prof. Dr. Hendrik Scholl, chief physician and head of the Basel University Eye Hospital. His presentation will highlightthe recent accomplishments in the field of retinal degeneration not only in basic research but most importantly in an unforeseen burst of clinical applications benefiting the visual impaired.Concluding an afternoon of science will be an evening session featuring Dr. Alexander Wilke who will critically highlight some of the issues surrounding pharmaceutical research in Germany but also worldwide.

PRO RETINA Germany, founded in 1977, is a patient organization with a longstanding commitment “to encourage ophthalmic research, to battle disease and to ensure a self-determined life of persons with retinal degeneration”. In continuation of its many activities in supporting these goals, PRO RETINA Germany has sponsored the Potsdam meeting series since its beginnings in 2005. PRO RETINA Germany also awards three poster prizes to young investigators selected from brief poster presentations. With these activities and platforms for meeting and communicating with senior and junior basic scientists as well as clinician scientist, clinicians and patients, we hope you enjoy the 2018 PRO RETINA Potsdam Symposium.

Preliminary Pro gra m

Friday, April 13, 2018

13:00 – 13:05 Welcome remarks Franz Badura

13:05 – 14:30 SESSION 1

Selected poster presentations

Eight abstracts to be selected

14:30 – 15:00 Keynote lecture

Hendrik Scholl, Basel- Cutting edge advances in the treatment of retinal degeneration

15:00 – 15:45 Coffee break

15:45 – 17:25 SESSION 2 New light on the retinal pigment epithelium (RPE)

15:45 – 16:10 Patric Turowski, London - Regulation of RPE function by ARMCproteins

16:10 – 16:35 Catherine Bowes Rickman, Durham -  Ocular exosomes as diagnostic and prognostic indicators for AMD

16:35 – 17:00 Emeline F. Nandrot, Paris -Circadian phagocytosis of outer segments

by RPE cells in health and disease: More complexity than meets the eye

17:00 – 17:25 Clare E. Futter, London - Modelling lysosome dysfunction in the

retinal pigment epithelium in early AMD

17:30 Dinner

19:00 – 20:00 E VENING LECTURE

Alexander Wilke, Huglfing - Pharmaceutical research yesterday, today and … ?

20:00 – open Swinging poster session

Saturday, April 14, 2018

09:00 – 10:40 SESSION 3 Gene therapy and retinal degeneration

09:00 – 09:25 Bernd Wissinger on behalf of the RD-CURE Consortium, Tübingen

  • First supplementary gene therapy for CNGA3-linked Achromatopsia

09:25 – 09:50 Alun Barnard, Oxford - Development and current status of gene

therapy for choroideremia

09:50 – 10:15 Kerstin Nagel-Wolfrum, Mainz - Usher-syndrome read-through therapy

10:15 – 10:40 Antoine Chaffiol, Paris - A new promoter allows optogenetic vision

restoration with enhanced sensitivity in macaque retina

10:40 – 11:15 Coffee break

11:15 – 12:55 SESSION 4 Targeting early and late AMD

11:15 – 11:40 Iris Heid, Regensburg - Understanding the progression from early

to late AMD

11:40 – 12:05 Horst Helbig, Regensburg Treating neovascular AMD by blocking

VEGF – Experiences

Oliver Zeitz, Berlin - Treating neovascular AMD by blocking

VEGF – Prospects

12:05 – 12:30 Steffen Schmitz-Valckenberg, Bonn - Atrophic AMD – outcome measurements

12:30 – 12:55 Cedric Francois, Cambridge, USA - Targeting atrophic AMD via the complement system – Complement factor 3

12:55 – 13:00 Concluding remarks

13:00 Lunch and end of meeting


To register Log onto www.potsdam-meeting.de The registration deadline is April 09, 2018.

Cancellation is free of charge until February 25, 2018. Thereafter registration fees cannot be reimbursed.



Join Our Mailing List